C6 WITH E-PATCH V 2.0 UNIVERSAL PATCH
Report
- Report Number
- 2133409-2022-00010
- Event Type
- Injury
- Date Received
- September 24, 2022
- Date of Event
- September 12, 2022
- Report Date
- September 23, 2022
- Manufacturer
- BRAEMAR MANUFACTURING, LLC
- Product Code
- DSI
- PMA / PMN Number
- K171410
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- 003
Narratives
THE MOST PROBABLE CAUSE OF THE THE SKIN CONDITION WAS ATTRIBUTABLE TO PATIENT PRE-EXISTING CONDITION OF SENSITIVE SKIN. MARSI, SKIN BURN, AND ASSOCIATED SYMPTOMS MAY INHERENTLY OCCUR UNDER THE COURSE OF ECG MONITORING. NO SINGLE FACTOR OR COMBINATION OF FACTORS CAN BE ATTRIBUTABLE TO ELECTRODE SKIN IRRITATION AND ASSOCIATED SYMPTOMS. THE PRODUCT LABELING ADVISES PATIENTS OF ALTERNATE OPTIONS AND OTHER STEPS TO TAKE IF SKIN IRRITATION DEVELOPS, INCLUDING HEALTHCARE PROFESSIONAL CONTACT AS NEEDED. PATCH IS UNAVAILABLE FOR EVALUATION. PATIENT WAS ADVISED BY CUSTOMER SUPPORT TO SWITCH TO USAGE OF THE LEAD WIRE ADAPTER TWICE PER DAY TO CONTINUE USAGE. PATIENT WAS ADVISED ON REQUIREMENT OF CHANGING AND ROTATING ELECTRODES AND TO USE WATER AND SOAP ON THE SKIN AREA. THE PATIENT'S PHYSICIAN INFORMED THE PATIENT TO USE A PRESCRIPTION CREAM THAT THE PATIENT ALREADY HAD FOR A PRIOR INFLAMMATORY SKIN CONDITION. NO ADDITIONAL PRESCRIPTION WAS WRITTEN.
BIOTEL HEART CUSTOMER SUPPORT NOTIFIED BRAEMAR THAT THE PATIENT CALLED WITH SKIN IRRITATION AND SOME BLEEDING FROM THE PATCH AND THAT NO SKIN PREP DONE. HER DOCTORS OFFICE USED ANTIBACTERIAL GEL TO TREAT THE SKIN CONDITION. THE DOCTOR INFORMED THE PATIENT TO USE A PRESCRIPTION CREAM THE PATIENT ALREADY HAD FOR INFLAMMATION (BETAMETHASONE VALERATE 0.1%). NO ADDITIONAL PRESCRIPTION WAS WRITTEN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1875491 | C6 WITH E-PATCH V 2.0 UNIVERSAL PATCH | C6 WITH E-PATCH V 2.0 UNIVERSAL PATCH | DSI | BRAEMAR MANUFACTURING, LLC | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 39 YR | Female | Other |